Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 521

1.

Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland.

Botteri E, Støer NC, Weiderpass E, Pukkala E, Ylikorkala O, Lyytinen H.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1857-1860. doi: 10.1158/1055-9965.EPI-19-0554. Epub 2019 Aug 27.

PMID:
31455672
2.

Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.

Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

BMJ. 2019 Mar 6;364:l665. doi: 10.1136/bmj.l665.

3.

Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse.

Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS.

Menopause. 2019 Feb;26(2):140-144. doi: 10.1097/GME.0000000000001173.

PMID:
29994974
4.

Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy.

Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS.

Int Urogynecol J. 2019 Feb;30(2):251-256. doi: 10.1007/s00192-018-3682-7. Epub 2018 Jun 26.

PMID:
29946829
5.

Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy.

Venetkoski M, Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Menopause. 2018 Apr;25(4):375-379. doi: 10.1097/GME.0000000000001023.

PMID:
29112596
6.

Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy.

Lantto H, Haapalahti P, Viitasalo M, Väänänen H, Sovijärvi ARA, Ylikorkala O, Mikkola TS.

Menopause. 2017 Dec;24(12):1386-1391. doi: 10.1097/GME.0000000000000932.

PMID:
28697043
7.

New evidence for cardiac benefit of postmenopausal hormone therapy.

Mikkola TS, Savolainen-Peltonen H, Venetkoski M, Ylikorkala O.

Climacteric. 2017 Feb;20(1):5-10. doi: 10.1080/13697137.2016.1262839. Epub 2017 Jan 2. Review.

PMID:
28042727
8.

Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users.

Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):870-877. doi: 10.1210/jc.2016-3590.

PMID:
27906568
9.

Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use.

Tuomikoski P, Salomaa V, Havulinna A, Airaksinen J, Ketonen M, Koukkunen H, Ukkola O, Kesäniemi YA, Lyytinen H, Ylikorkala O, Mikkola TS.

Maturitas. 2016 Dec;94:106-109. doi: 10.1016/j.maturitas.2016.09.015. Epub 2016 Sep 28.

PMID:
27823727
10.

Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study.

Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Menopause. 2016 Nov;23(11):1199-1203.

PMID:
27465718
11.

Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies.

Savolainen-Peltonen H, Tuomikoski P, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

J Clin Endocrinol Metab. 2016 Jul;101(7):2794-801. doi: 10.1210/jc.2015-4149. Epub 2016 May 12.

PMID:
27172432
12.

Vaginal estradiol use and the risk for cardiovascular mortality.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Hum Reprod. 2016 Apr;31(4):804-9. doi: 10.1093/humrep/dew014. Epub 2016 Feb 13.

PMID:
26874358
13.

Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

J Clin Endocrinol Metab. 2015 Dec;100(12):4588-94. doi: 10.1210/jc.2015-1864. Epub 2015 Sep 28.

PMID:
26414962
14.

The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study.

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Maturitas. 2015 Jul;81(3):384-8. doi: 10.1016/j.maturitas.2015.04.002. Epub 2015 Apr 13.

PMID:
25912424
15.

Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.

Koskela-Niska V, Pukkala E, Lyytinen H, Ylikorkala O, Dyba T.

Int J Cancer. 2015 Oct 15;137(8):1947-52. doi: 10.1002/ijc.29549. Epub 2015 Apr 21.

16.

Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Menopause. 2015 Sep;22(9):976-83. doi: 10.1097/GME.0000000000000450.

PMID:
25803671
17.

[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative].

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Duodecim. 2014;130(21):2209. Finnish. No abstract available.

PMID:
25582016
18.

Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative.

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Obstet Gynecol. 2014 Nov;124(5):947-53. doi: 10.1097/AOG.0000000000000461.

PMID:
25437723
19.

Postmenopausal hot flushes and bone mineral density: a longitudinal study.

Tuomikoski P, Ylikorkala O, Mikkola TS.

Acta Obstet Gynecol Scand. 2015 Feb;94(2):198-203. doi: 10.1111/aogs.12546. Epub 2014 Dec 25.

PMID:
25421213
20.

Premenstrual symptoms in fertile age are associated with impaired quality of life, but not hot flashes, in recently postmenopausal women.

Hautamäki H, Haapalahti P, Savolainen-Peltonen H, Tuomikoski P, Ylikorkala O, Mikkola TS.

Menopause. 2014 Dec;21(12):1287-91. doi: 10.1097/GME.0000000000000247.

PMID:
24824645
21.

Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy.

Savolainen-Peltonen H, Hautamäki H, Tuomikoski P, Ylikorkala O, Mikkola TS.

Menopause. 2014 Jul;21(7):732-9. doi: 10.1097/GME.0000000000000120.

PMID:
24219882
22.

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.

Goldstein SR, Bachmann GA, Koninckx PR, Lin VH, Portman DJ, Ylikorkala O; Ospemifene Study Group.

Climacteric. 2014 Apr;17(2):173-82. doi: 10.3109/13697137.2013.834493. Epub 2013 Nov 23.

23.

Sex differences in age-related cardiovascular mortality.

Mikkola TS, Gissler M, Merikukka M, Tuomikoski P, Ylikorkala O.

PLoS One. 2013 May 20;8(5):e63347. doi: 10.1371/journal.pone.0063347. Print 2013.

24.

Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.

Koskela-Niska V, Pukkala E, Lyytinen H, Ylikorkala O, Dyba T.

Int J Cancer. 2013 Oct 1;133(7):1680-8. doi: 10.1002/ijc.28167. Epub 2013 Apr 16.

25.

Smoking is accompanied by a suppressed cervical nitric oxide release in women with high-risk human papillomavirus infection.

Rahkola-Soisalo P, Mikkola TS, Vuorento S, Ylikorkala O, Väisänen-Tommiska M.

Acta Obstet Gynecol Scand. 2013 Jun;92(6):711-5. doi: 10.1111/aogs.12119. Epub 2013 Mar 29.

PMID:
23451878
26.

Decreasing perinatal mortality in placental abruption.

Tikkanen M, Luukkaala T, Gissler M, Ritvanen A, Ylikorkala O, Paavonen J, Nuutila M, Andersson S, Metsäranta M.

Acta Obstet Gynecol Scand. 2013 Mar;92(3):298-305. doi: 10.1111/aogs.12030. Epub 2012 Dec 5.

PMID:
23072758
27.

Menopausal hot flashes and insulin resistance.

Tuomikoski P, Ylikorkala O, Mikkola TS.

Menopause. 2012 Oct;19(10):1116-20.

PMID:
22668816
28.

Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.

Koskela-Niska V, Lyytinen H, Riska A, Pukkala E, Ylikorkala O.

Climacteric. 2013 Feb;16(1):48-53. doi: 10.3109/13697137.2012.663818. Epub 2012 May 28.

PMID:
22640598
29.

Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland.

Koskela-Niska V, Riska A, Lyytinen H, Pukkala E, Ylikorkala O.

Gynecol Oncol. 2012 Aug;126(2):241-4. doi: 10.1016/j.ygyno.2012.04.045. Epub 2012 May 2.

PMID:
22561401
30.

Effect of hot flushes on cardiovascular autonomic responsiveness: a randomized controlled trial on hormone therapy.

Hautamäki H, Haapalahti P, Piirilä P, Tuomikoski P, Sovijärvi A, Ylikorkala O, Mikkola TS.

Maturitas. 2012 Jul;72(3):243-8. doi: 10.1016/j.maturitas.2012.04.001. Epub 2012 Apr 24.

PMID:
22537767
31.

High-risk human papillomavirus-induced expression of endothelial and inducible nitric oxide synthase in human uterine cervix.

Rahkola-Soisalo P, Savolainen-Peltonen H, Väisänen-Tommiska M, Butzow R, Ylikorkala O, Mikkola TS.

Ann Med. 2013 Feb;45(1):79-84. doi: 10.3109/07853890.2012.665472. Epub 2012 Mar 16.

PMID:
22420338
32.

A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.

Korhonen K, Auvinen A, Lyytinen H, Ylikorkala O, Pukkala E.

Am J Epidemiol. 2012 Feb 15;175(4):309-14. doi: 10.1093/aje/kwr335. Epub 2012 Jan 27.

PMID:
22287638
33.

Hormone therapy and vasomotor symptoms.

Tuomikoski P, Mikkola TS, Ylikorkala O.

Menopause. 2011 Dec;18(12):1335. doi: 10.1097/GME.0b013e31823bbbb5. No abstract available.

PMID:
22138572
34.

Letter to the Editor.

Tuomikoski P, Mikkola TS, Ylikorkala O.

Menopause. 2011 Nov 18. [Epub ahead of print] No abstract available.

PMID:
22105150
35.

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

Jaakkola S, Pukkala E, K Lyytinen H, Ylikorkala O.

Int J Cancer. 2012 Aug 15;131(4):E537-43. doi: 10.1002/ijc.27321. Epub 2011 Dec 14.

36.

Plasma nitrite/nitrate levels in women with postmenopausal hot flushes.

Tuomikoski P, Ylikorkala O, Mikkola TS.

Climacteric. 2012 Apr;15(2):153-6. doi: 10.3109/13697137.2011.597894. Epub 2011 Oct 23.

PMID:
22017369
37.

Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.

Lantto H, Haapalahti P, Tuomikoski P, Viitasalo M, Väänänen H, Sovijärvi AR, Ylikorkala O, Mikkola TS.

Menopause. 2012 Jan;19(1):82-8. doi: 10.1097/gme.0b013e318221bae8.

PMID:
21934534
38.

Cervical nitric oxide release in Chlamydia trachomatis and high-risk human papillomavirus infection.

Rahkola P, Väisänen-Tommiska M, Hiltunen-Back E, Auvinen E, Ylikorkala O, Mikkola TS.

Acta Obstet Gynecol Scand. 2011 Sep;90(9):961-5. doi: 10.1111/j.1600-0412.2011.01205.x. Epub 2011 Jul 18.

PMID:
21644935
39.

Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas.

Jaakkola S, Lyytinen HK, Pukkala E, Ylikorkala O.

Gynecol Oncol. 2011 Aug;122(2):260-3. doi: 10.1016/j.ygyno.2011.04.003. Epub 2011 Apr 30.

PMID:
21531011
40.

[Hormone therapy and risk for breast cancer in Finnish postmenopausal women].

Lyytinen H, Ylikorkala O.

Duodecim. 2011;127(3):235-42. Finnish.

PMID:
21438346
41.

Cardiovascular autonomic responsiveness in postmenopausal women with and without hot flushes.

Hautamäki H, Piirilä P, Haapalahti P, Tuomikoski P, Sovijärvi AR, Ylikorkala O, Mikkola TS.

Maturitas. 2011 Apr;68(4):368-73. doi: 10.1016/j.maturitas.2011.01.004.

PMID:
21310559
42.

Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study.

Jaakkola S, Lyytinen HK, Dyba T, Ylikorkala O, Pukkala E.

Int J Cancer. 2011 Apr 1;128(7):1644-51. doi: 10.1002/ijc.25762. Epub 2011 Jan 12.

43.

Menopausal hot flushes and vascular health.

Tuomikoski P, Ylikorkala O, Mikkola TS.

Ann Med. 2011 Jun;43(4):283-91. doi: 10.3109/07853890.2010.546364. Epub 2011 Jan 24. Review.

PMID:
21254907
44.

Cervical nitric oxide release and persistence of high-risk human papillomavirus in women.

Rahkola P, Väisänen-Tommiska M, Tuomikoski P, Ylikorkala O, Mikkola TS.

Int J Cancer. 2011 Jun 15;128(12):2933-7. doi: 10.1002/ijc.25637. Epub 2010 Nov 9.

45.

Self-reported smoking habits and serum cotinine levels in women with placental abruption.

Tikkanen M, Surcel HM, Bloigu A, Nuutila M, Ylikorkala O, Hiilesmaa V, Paavonen J.

Acta Obstet Gynecol Scand. 2010 Dec;89(12):1538-44. doi: 10.3109/00016349.2010.526187. Epub 2010 Nov 5.

PMID:
21050148
46.

Per Bergsjö, in memoriam.

Janson PO, Fischer-Rasmussen W, Grénman S, Hornnes P, Geirsson RT, Hamberger L, Kirste U, Ylikorkala O, Berg G, Kjessler B, Nesheim BI.

Acta Obstet Gynecol Scand. 2010 Oct;89(10):1244-5. doi: 10.3109/00016349.2010.520526. No abstract available.

PMID:
20846056
47.

Endometriosis and assisted reproduction techniques.

Härkki P, Tiitinen A, Ylikorkala O.

Ann N Y Acad Sci. 2010 Sep;1205:207-13. doi: 10.1111/j.1749-6632.2010.05656.x. Review.

PMID:
20840274
48.

Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.

Tuomikoski P, Mikkola TS, Tikkanen MJ, Ylikorkala O.

Climacteric. 2010 Oct;13(5):457-66. doi: 10.3109/13697131003624656.

PMID:
20443719
49.

Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.

Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.

Ann Med. 2010 Jul;42(5):334-43. doi: 10.3109/07853891003796760.

PMID:
20429800
50.

Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women.

Tuomikoski P, Haapalahti P, Ylikorkala O, Mikkola TS.

Ann Med. 2010 Apr;42(3):216-22. doi: 10.3109/07853891003657319.

PMID:
20384436

Supplemental Content

Loading ...
Support Center